DaVita
DVA
#1675
Rank
NZ$22.02 B
Marketcap
NZ$343.18
Share price
0.18%
Change (1 day)
48.92%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): NZ$18.80

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$19.01. In 2025 the company made an earnings per share (EPS) of NZ$17.49 a decrease over its 2024 EPS that were of NZ$19.07.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$18.807.47%
2025NZ$17.49-8.25%
2024NZ$19.0744.94%
2023NZ$13.1527.26%
2022NZ$10.34-35.56%
2021NZ$16.0444.1%
2020NZ$11.1319.7%
2019NZ$9.30540.48%
2018NZ$1.45-76.07%
2017NZ$6.07-19.31%
2016NZ$7.52242.52%
2015NZ$2.20-62.87%
2014NZ$5.9113.43%
2013NZ$5.218.45%
2012NZ$4.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$42.02 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$19.64 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$33.62 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.34-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA